View Older Stories View More Recent Stories
-
McDonald's (MCD) PT Lowered to $250 at Baird
-
Ocugen gets provisional approval in Bahamas for RP gene therapy OCU400
-
Aurora Innovation (AUR) Reiterated at Overweight by Cantor Fitzgerald - Leader in Autonomous Trucks
-
Hovde Group Starts Park National (PRK) at Market Perform
-
FDA grants priority review to AstraZeneca's Imfinzi combo for bladder cancer
-
Legend Biotech reports 50% of myeloma patients progression-free at 5 years
-
Atlas Energy Solutions signs power equipment deals with AI lab
-
Reborn Coffee signs non-binding MOU with Visvita for RTD and supply
-
Fate Therapeutics gets $15M CIRM grant for lupus nephritis trial
-
Libra Energy to Participate in CEM's Muskoka Capital Event
-
White Gold Corp. Announces Filing of Preliminary Economic Assessment with C$1.86 Billion After-Tax NPV, 41% IRR and 1.5 Year Payback Period on the White Gold Project, Yukon, Canada
-
UraniumX Plans Winter Gravity Program at Murphy Lake as Q4 Assays Approach
-
Buffalo Potash Completes Final Horizontal Well and Concludes Successful Drilling Program
-
Core Silver Announces Grant of Stock Options
-
American Hotel Income Properties REIT LP Announces Corporate Update
-
ATA Critical Event Services Expands From Three Partners to a Network of More Than 20
-
Sirios Begins Drilling at the Aquilon Gold Project in Eeyou Istchee James Bay, Quebec
-
Why stocks held up despite rising yields and $100 oil? These 2 words explain it
-
Stock action shows confidence in central banks: BofA’s Hartnett
-
Meta Platforms Inc. (META) PT Raised to $950 at Canaccord
-
BlackBerry (BB) PT Lowered to $9.50 at Canaccord
-
H.C. Wainwright Reiterates Buy Rating on Coya Therapeutics (COYA)
-
H.C. Wainwright Reiterates Buy Rating on Abeona Therapeutics (ABEO)
-
H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)
-
Surrozen Inc. (SRZN) PT Raised to $54 at H.C. Wainwright
-
H.C. Wainwright Reiterates Buy Rating on Kyverna Therapeutics Inc (KYTX)
-
H.C. Wainwright Reiterates Buy Rating on Ultragenyx Pharma (RARE)
-
H.C. Wainwright Reiterates Buy Rating on Axsome Therapeutics (AXSM)
-
Zscaler (ZS) PT Raised to $220 at Mizuho
-
Pelican AI to Attend Sibos 2026 in Miami to Advance Global Banking Relationships
-
GRAIL, Inc. (GRAL) PT Raised to $100 at Mizuho
-
Darden Restaurants (DRI) PT Raised to $245 at Mizuho
-
Costco Wholesale (COST) PT Lowered to $1,065 at Mizuho
-
Charles River Labs (CRL) PT Raised to $295 at Mizuho
-
Mizuho Reiterates Outperform Rating on SpaceX (SPCX)
-
Truist Securities Upgrades First Financial Bancorp (FFBC) to Buy, 'Rising Rates = Rising Estimates'
-
BofA Securities Downgrades Nike (NKE) to Underperform
-
Veon and Square Group win Bangladesh digital bank license
-
StoneX Starts Viking Holdings (VIK) at Buy
-
Needham Starts PDF Solutions Inc. (PDFS) at Buy
-
Damora Therapeutics (DMRA) PT Raised to $60 at Guggenheim
-
Valaris plc (VAL) files $500M mixed shelf
-
Kimberly Clark (KMB) PT Lowered to $120 at BofA Securities
-
Grab Holdings Inc. (GRAB) PT Lowered to $4.50 at BofA Securities
-
Akamai Technologies (AKAM) PT Raised to $185 at BofA Securities
-
Fervo Energy (FRVO) PT Lowered to $30 at BofA Securities
-
Kremlin says US, Russia, Ukraine meeting may happen soon
-
Canaccord Starts Merlin Labs (MRLN) at Buy
-
Lowe's Cos. (LOW) call put ratio 1 call 1.5 puts as share price near low end of range
-
Home Depot (HD) call put ratio 1 call 1 put as share price near low end of range
